Page 3 - Protochips Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Protochips inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Protochips Inc Today - Breaking & Trending Today

Tiny SARS-CoV-2 protein may have big implications for future COVID-19 treatments


Tiny SARS-CoV-2 protein may have big implications for future COVID-19 treatments
A tiny protein of SARS-CoV-2, the coronavirus that gives rise to COVID-19, may have big implications for future treatments, according to a team of Penn State researchers.
Using a novel toolkit of approaches, the scientists uncovered the first full structure of the Nucleocapsid (N) protein and discovered how antibodies from COVID-19 patients interact with that protein. They also determined that the structure appears similar across many coronaviruses, including recent COVID-19 variants making it an ideal target for advanced treatments and vaccines. They reported their results in
Nanoscale.
We discovered new features about the N protein structure that could have large implications in antibody testing and the long-term effects of all SARS-related pandemic viruses. Since it appears that the N protein is conserved across the variants of SARS-CoV-2 and SARS-CoV-1, therapeutics designed to ....

South Africa , United States , United Kingdom , Deb Kelly , Michael Casasanta , Emily Henderson , Penn State Center , Protochips Inc , Penn State , Huck Chair , Molecular Biophysics , Raybiotech Life , Direct Electron , Corona Virus , Sars Cov 2 , Spike Protein , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , டெப் கெல்லி , எமிலி ஹென்டர்சன் , பென் நிலை மையம் , பென் நிலை , ஹக் நாற்காலி , மூலக்கூறு உயிர் இயற்பியல் , நேரடி எதிர் மின்னணு , கொரோனா வைரஸ் ,

Nanotechnology Now - Press Release: Antibody binding-site conserved across COVID-19 virus variants: The structural revelation could have implications as a therapeutic target in all SARS-CoV-2 variants


Our NanoNews Digest Sponsors
Home > Press > Antibody binding-site conserved across COVID-19 virus variants: The structural revelation could have implications as a therapeutic target in all SARS-CoV-2 variants
A Penn State research team found that the N protein on SARS-CoV-2 is conserved across all SARS-related pandemic coronaviruses (top, from left: SARS-CoV-2, civet, SARS-CoV, MERS). The protein differs from other coronaviruses, such as those that cause the common cold (bottom, from left: OC43, HKU1, NL63 and 229E).
CREDIT
Kelly Lab/Penn State
Abstract:
A tiny protein of SARS-CoV-2, the coronavirus that gives rise to COVID-19, may have big implications for future treatments, according to a team of Penn State researchers. ....

South Africa , United States , United Kingdom , Williamy Luqiu , Megan Lakatos , Williamj Dearnaley , Mariaj Solares , Mariah Schroen , Deb Kelly , Jared Wilson , Michael Casasanta , University Park , Penn State Center , Kelly Lab Penn , Integrative Biosciences Graduate Program , Penn State Materials Research Institute , Computer Engineering At Duke University , Department Of Electrical , Protochips Inc , Huck Institutes Of The Life Sciences , Wave Inc , Home Press Antibody , Penn State , Huck Chair , Molecular Biophysics , Structural Oncology ,

Antibody binding-site conserved across COVID-19 virus variants


Date Time
Antibody binding-site conserved across COVID-19 virus variants
A Penn State research team found that the N protein on SARS-CoV-2 is conserved across all SARS-related pandemic coronaviruses (top, from left: SARS-CoV-2, civet, SARS-CoV, MERS). The protein differs from other coronaviruses, such as those that cause the common cold (bottom, from left: OC43, HKU1, NL63 and 229E).
Image: Kelly Lab/Penn State
A tiny protein of SARS-CoV-2, the coronavirus that gives rise to COVID-19, may have big implications for future treatments, according to a team of Penn State researchers.
Using a novel toolkit of approaches, the scientists uncovered the first full structure of the Nucleocapsid (N) protein and discovered how antibodies from COVID-19 patients interact with that protein. They also determined that the structure appears similar across many coronaviruses, including recent COVID-19 variants – making it an ideal target for advanced treatments and vaccines. The ....

South Africa , United States , United Kingdom , Williamy Luqiu , Mariah Schroen , Jared Wilson , Deb Kelly , Michael Casasanta , Williamj Dearnaley , Mariaj Solares , Penn State Center , Integrative Biosciences Graduate Program , Penn State Materials Research Institute , Computer Engineering At Duke University , Department Of Electrical , Protochips Inc , Huck Institutes Of The Life Sciences , Penn State , Huck Chair , Molecular Biophysics , Structural Oncology , Raybiotech Life , Direct Electron , Materials Research Institute , Genomics Graduate Program , Huck Institutes ,